Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Photys Therapeutics in the transaction. Photys Therapeutics (Photys), a proximity-based therapeutics company, announced its multi-year collaboration and license...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Wellington Management in the transaction. Metsera, a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity...
You must be a Standard 1 Year member to access this content.
Cooley, Goodwin Procter and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Arsenal Biosciences on the transaction. Arsenal Biosciences (ArsenalBio) announced raising $325 million in Series...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented MassMutual Ventures in the transaction. Cultivo announced it raised $14 million in Series A financing, to accelerate its mission...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented MassMutual Ventures in the transaction. Prove Identity announced $40 million funding round led by MassMutual Ventures and Capital One Ventures. The...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Osmoses in the transaction. Osmoses announced its $11 million Series Seed financing led by Energy Capital Ventures, and included...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Solu Therapeutics in the transaction. Solu Therapeutics announced the closing of an oversubscribed $31 million seed financing co-led...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented LightForce Orthodontics in the transaction. LightForce Orthodontics announced its $80 million Series D financing led by Ally Bridge Group....
You must be a Standard 1 Year member to access this content.
Weil, Gotshal & Manges LLP represented AltC Acquisition Corp., while Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP represented Oklo Inc. in the transaction. An advanced...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Spark Capital on the deal. Anthropic, the prominent generative AI startup co-founded by OpenAI veterans, has raised $450 million in Series C funding...
You must be a Standard 1 Year member to access this content.
CMS Carey & Allende and Wilmer Cutler Pickering Hale and Dorr advised Toku, while Carey & Co. and Gunderson Dettmer advised F-Prime on the transaction. Toku closed...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented RIGImmune on the deal. RIGImmune, a biopharmaceutical company developing a new class of RNA immunotherapeutics, announced its acquisition of Subintro, a biotechnology company specializing...
You must be a Standard 1 Year member to access this content.
